zomig rapimelt suus dispergeeruv tablett
astrazeneca uk limited - zolmitriptaan - suus dispergeeruv tablett - 2,5mg 2tk
ciprofloxacin olainfarm õhukese polümeerikattega tablett
olainfarm as - tsiprofloksatsiin - õhukese polümeerikattega tablett - 500mg 10tk; 500mg 20tk
haloperidol decanoate-richter süstelahus
gedeon richter plc. - haloperidool - süstelahus - 50mg 1ml 1ml 5tk
ciprinol õhukese polümeerikattega tablett
krka, d.d., novo mesto - tsiprofloksatsiin - õhukese polümeerikattega tablett - 500mg 10tk
ciprofloxacin norameda infusioonilahus
norameda uab - tsiprofloksatsiin - infusioonilahus - 2mg 1ml 100ml 10tk; 2mg 1ml 200ml 10tk
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - muud närvisüsteemi ravimid - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
produodopa infusioonilahus
abbvie sia - foslevodopa+foskarbidopa - infusioonilahus - 240mg+12mg 1ml 10ml 7tk
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosupressandid - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - sclerosis multiplex, relapsing-remitting - immunosuppressants, valikuline immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
terebyo õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - teriflunomiid - õhukese polümeerikattega tablett - 14mg 84tk; 14mg 28tk